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Spectroscopic oximetry in the eye: a review 18 
ABSTRACT 19 
Introduction: Non-invasive measurement of blood oxygen saturation via spectroscopic imaging has 20 
facilitated insights into the development and progression of a variety of ocular conditions, including 21 
retinal vascular occlusion, diabetic retinopathy and glaucoma.  Major developments since the late 90s 22 
have been enabled by advancements in imaging technology, computational image analysis, and 23 
experimental methods.  24 
Areas covered: We review the theory of spectroscopic oximetry, the ocular blood vessels targeted for 25 
oximetry, imaging systems used for oximetry, and oximetry validation methods. Important 26 
physiological and clinical insights provided by oximetry in the eye are detailed. 27 
Expert commentary: Oximetry has revealed physiological norms and auto-regulatory effects in the 28 
retina, choroid, episcleral, and bulbar conjunctival blood vessels. Retinal oximetry has provided crucial 29 
insight into the development of diabetic retinopathy and glaucoma, and has enhanced the evaluation 30 
and treatment of retinal vessel occlusion. Commercially available retinal oximetry systems have 31 
enabled oximetry in the clinic. The development more sophisticated phantoms that resemble in vivo 32 
environments has oximetry validation in diverse oximetry applications. New insights into ocular 33 
physiology and disease are likely to be gleaned from future studies. 34 
-------------------------------------------------------------------------------------------------------------------------------------- 35 
Keywords: oximetry, retina, autoregulation, diabetes, glaucoma, vessel occlusion, choroid, bulbar 36 
conjunctiva. 37 
 38 
1. INTRODUCTION  39 
Oximetry - the measurement of blood oxygen saturation (OS)  W can be achieved non-invasively by 40 
measuring the spectrum of light absorbed by blood. This is achieved by imaging the eye at two or more 41 
wavelengths of light, and calibrating the OS to absorption of light by either (1) assuming standard 42 
normal OS values or (2), by combining information from many wavelengths into a sophisticated 43 
physical model incorporating the known spectral properties of blood with other biological and optical 44 
parameters. 45 
Since the late 1950s, retinal oximetry has progressed from a photographic technique [1 W3] through 46 
to the cutting edge of digital imaging technology with automated computational analysis.[4,5] Over 47 
the decades, retinal oximetry has revealed valuable insights into retinal physiology and metabolism 48 
under conditions such as flicker illumination,[6,7] dark adaptation,[8] hyperoxia,[4,9,10] and acute 49 
mild hypoxia.[11,12] Further, retinal oximetry has provided insights into the development and 50 
progression of ocular diseases such as diabetic retinopathy,[13 W17] glaucoma,[18 W22] and retinal 51 
vessel occlusion.[23 W26] Recently, oximetry has allowed the understanding of the fundamental 52 
physiological oxygen dynamics of the bulbar conjunctival circulation,[27] the episcleral vessels,[27] 53 
and the choroidal circulation.[28]  54 
&ƌŽŵ Ă ƉĂƚŝĞŶƚ ?Ɛ ƉĞƌƐƉĞĐƚŝǀĞ ? ƚŚĞ ĞǆƉĞƌŝĞŶĐĞ ŽĨ ŽǆŝŵĞƚƌǇ ŝŵĂŐŝŶŐ ŝŶ ƚŚĞ ĞǇĞ ŝƐ typically 55 
indistinguishable from conventional retinal-fundus imaging because oximetry systems are typically 56 
based on a modified conventional retinal-fundus cameras[4,11,16] or multi-wavelength scanning laser 57 
ophthalmoscopes.[10,29] As such, a great deal of oximetry innovation has arisen from improved 58 
image recording, computational image analysis, and the development of complimentary functional 59 
oxygen-sensitive stress interventions that allow insight into OS under altered metabolic conditions. 60 
These intervention tests include subjecting subjects to hyperoxia,[6,7] acute mild hypoxia,[11,12] or 61 
altered light-exposure conditions.[6 W8] As well as physiological and clinical insights, these intervention 62 
tests help validate the accuracy of oximetry measurements. 63 
Invariably, advances in oximetric-imaging technology have provided new insights and applications. 64 
In particular, the development of commercially available retinal oximetry devices with automated 65 
analysis  W such as the Oxymap T1 (Oxymap ehf, Iceland )[4] and Imedos (Imedos Systems UG, 66 
Germany)[16] retinal oximetry systems - have enabled oximetry in the clinic, allowing insights into 67 
treatment of individual patients[24] and also enabling clinicians to build large datasets with high 68 
statistical power. Additionally, the development of oximetry systems with capability for imaging with 69 
greater temporal[11] and spatial resolution[29] enable development of novel techniques and fresh 70 
insights by investigating OS of smaller blood vessels or by studying OS dynamics on a shorter timescale. 71 
For example, snapshot multispectral imaging technology has enabled measurement of rapid oxygen 72 
diffusion in the bulbar conjunctiva[27] and adaptive optics have enabled oximetry in small retinal 73 
vessels, which are not typically studied due to their small diameters.[29] 74 
This review focuses on the current technology and methods of spectroscopic oximetry, new 75 
applications in spectroscopic oximetry of the eye, and the clinically useful ophthalmological insights 76 
that have been consequently enabled. 77 
2. PRINCIPLE OF SPECTROSCOPIC OXIMETRY 78 
Spectroscopic oximetry is enabled by the distinct absorption spectra of oxygenated haemoglobin 79 
(O2Hb) and deoxygenated haemoglobin (Hb) as shown in Figure 1: partial oxygenation results in an 80 
absorption spectrum that is a weighted average of these two spectra. This difference in optical 81 
absorption can be clearly seen by eye for a low-volume sample of blood: highly oxygenated blood 82 
appears bright red to the eye, whereas deoxygenated blood is much darker in appearance. Whilst this 83 
difference in optical absorption is readily observed in ex vivo blood samples, it is highly challenging to 84 
accurately quantify in the complex optical environment of the eye due to the influence of optical 85 
scattering[30] and the uncertain absorption of light by variable background pigmentation.[9,31] There 86 
are two approaches to spectroscopic oximetry measurement and analysis: two-wavelength oximetry 87 
and multi-wavelength oximetry.  88 
 89 
 90 
Figure 1. The absorption spectra of oxygenated haemoglobin (O2Hb) and deoxygenated 91 
haemoglobin (Hb) at visible and near infra-red wavelengths. 92 
2.1. Two-wavelength oximetry 93 
In two-wavelength oximetry, blood vessels are imaged at one OS-sensitive contrast wavelength, 94 
and another  W typically OS-insensitive (isobestic) - wavelength. The optical transmission of blood 95 
vessels ሺ ఒܶሻ is measured at each wavelength, and the optical density ሺܱܦሻ, defined as: ܱܦఒ ൌ96 െ݈݋ ݃ሺ ఒܶሻǡ is computed. From this, the optical density ratio ሺܱܦܴሻ, defined as ܱܦܴ ൌ  ை஽ഊ೎೚೙೟ೝೌೞ೟ை஽ഊ೔ೞ೚್೐ೞ೟೔೎ǡis 97 
calculated. If an isobestic wavelength is used, then for a blood vessel of a given diameter, ODR is 98 
theoretically directly proportional to blood oxygen saturation (verified experimentally in 1959)[1], and 99 
so ODR can be empirically related to OS by measuring ODR of blood vessels at two OS levels followed 100 
by calibration against a blood vessels of known oxygenation (i.e. using pulse oximetry or blood gas 101 
measurement). The theory of two-wavelength oximetry is based upon the simple Beer-Lambert law 102 
of light transmission, which neglects the effects of optical scattering that is incorporated into the 103 
modified Beer-Lambert law.[31] For visualisation purposes, ODR or OS is often overlaid as a colour 104 
map on images of blood vessels (see Figure 2 for an example).[4] 105 
 106 
Figure 2. ODR colour-map of bulbar conjunctiva (BC) and episcleral (ES) vessels at (a) 107 
normoxia, and (b) acute mild hypoxia. Reproduced with permission from MacKenzie et 108 
al., (2016).[32] 109 
The optimal transmission of a blood vessel for accurate oximetry is around 37%, [33] but, because 110 
the optical transmission of blood vessels varies  according to several factors  W including vessel 111 
diameter -  an optical transmission of between 10 % and 70 % has been found to work well.[33] For 112 
retinal oximetry, the combination of 570 nm (isobestic) and 600 nm (contrast) wavebands has been 113 
commonly adopted for retinal oximetry.[4,11,31] However, the optimal wavelength combinations 114 
used for any oximetry study are dependent upon the calibre of vessels of interest and the efficiency 115 
of optical imaging and detection systems.  116 
Care is required in calibration of two-wavelength oximetry. In early retinal oximetry studies retinal 117 
arterial OS was calibrated by comparison with ex vivo brachial-artery blood samples and blood gas 118 
measurement.[1 W3] Whilst useful for establishing relations between retinal arterial OS and systemic 119 
arterial OS, ex vivo blood gas measurement is undesirable or not feasible and has been rendered 120 
unnecessary by the advent of fingertip pulse oximetry which allows non-invasive estimation of 121 
systemic arterial OS. However, calibrating arterial OS alone can lead to artefacts in estimated venous 122 
OS. For example, it has been shown that ODR is dependent on blood vessel diameter and background 123 
pigmentation; so two-wavelength oximetry requires calibration correction factors that are dependent 124 
upon both background pigmentation and blood vessel diameter.[9,31]  It has recently been postulated 125 
that the laminar flow from multiple tributary branching veins, which  leads to non-inform blood 126 
oxygenation within a vein may also degrade estimation of OS in retinal veins, which is based upon 127 
homogeneous blood oxygenation. This significance of this factor requires experimental testing and 128 
validation.[34] 129 
Two-wavelength oximetry is the basis for the Oxymap and Imedos commercial retinal imaging 130 
devices which have found considerable use in clinical applications (see Section 6). 131 
2.2. Multispectral oximetry techniques 132 
Multispectral oximetry is broadly defined as any oximetry technique that incorporates information 133 
from three or more spectral wavebands to calculate OS. 134 
2.2.1. Three-wavelength oximetry  135 
The simplest form of multispectral oximetry, three-wavelength oximetry, [35] utilises two isobestic 136 
wavelengths relatively close to each other on the wavelength spectra combined with a wavelength 137 
providing oximetric contrast. From the two isobestic two wavelengths it is possible to quantify the 138 
scattering of light by blood, and thus to appropriately alter estimation of blood-vessel transmission 139 
via the modified Beer Lambert law.[35] Three-wavelength retinal oximetry was applied to the retinal 140 
imaging with a scanning laser device by Delori in the 1980s and 1990s.[36,37] However, three 141 
wavelength oximetry was somewhat difficult to apply because of the requirements of three 142 
wavebands where blood exhibits similar optical scattering properties; this limited the range of useful 143 
wavebands to which it can be applied.[33] As such, three-wavelength oximetry has tended to be 144 
superseded by multispectral oximetry using four or more bands. 145 
2.2.2. Multispectral oximetry models 146 
Multispectral oximetry models enable estimation of OS by incorporating the optical transmission 147 
of blood at a number of wavebands to isolate the absorption of light by blood and estimate or 148 
compensate for other optical parameters, e.g. the scattering of light by blood and tissue, or the optical 149 
absorption by melanin pigmentation. Typically, the transmissions of blood vessels are measured and 150 
the experimental transmission compared to a theoretical model incorporating these parameters. This 151 
enables direct estimation of OS without need of a reference value; i.e. multispectral algorithms are 152 
 “ĐĂůŝďƌĂƚŝŽŶĨƌĞĞ ? ?dŚƵƐ ?ŵƵůƚŝƐƉĞĐƚƌĂůŽǆŝŵĞƚƌǇĂůŐŽƌŝƚŚŵƐcan provide quantitative oximetry in blood 153 
vessels where OS levels have not yet been measured by other means (e.g. in the spinal cord)[38] or in 154 
blood vessels that may be expected to be very different from physiological norms (e.g. studying 155 
angiogenesis in tumour development)[39,40]. However, validation of estimated OS from multispectral 156 
oximetry algorithms is normally desirable, and provides vital information for the wider field of 157 
oximetry (see Section 5).  158 
The number of wavebands incorporated into a multispectral imaging system varies greatly. Some 159 
oximetry studies incorporate many wavebands (e.g. between 25 and 76 wavebands) into a 160 
 ?ŚǇƉĞƌƐƉĞĐƚƌĂů ?ŵŽĚĞů  ?ƐĞĞ dĂďůĞ  ? ) ? ,ǇƉĞƌƐƉĞĐƚƌĂů ŝŵĂŐŝŶŐ ŽĨĨĞƌƐ ƚŚĞĂĚǀĂŶƚĂŐĞ Ă comprehensive 161 
measurement of blood vessel transmission, but as a result of this, hyperspectral imaging systems are 162 
typically burdened with a long acquisition time (i.e. > 1 minute) and high data volumes for a single 163 
data set. Consequently, challenges arise from subject eye motion and alterations of OS of vessels 164 
during hyperspectral measurement. Additionally, some wavebands may be sub-optimal for oximetry; 165 
for example, blue wavelengths suffer from lower instrumental signal-to-noise ratios and high 166 
absorption by melanin pigmentation, and auto-fluorescence from blood or other tissue. Imaging 167 
spectrograph devices offer excellent spectral resolution and have been employed for spectroscopy of 168 
the eye,[41] but have only found limited usage because there are no significant advantages associated 169 
with over-sampling the absorbance spectra of blood for oximetry. 170 
Multispectral oximetry models incorporating a few (typically < 10) key wavelengths have achieved 171 
high quality oximetry, whilst reducing acquisition time required for spectral data acquisition. Of 172 
ƉĂƌƚŝĐƵůĂƌ ŶŽƚĞ ŝƐ ƚŚĞ ĚĞǀĞůŽƉŵĞŶƚ ŽĨ  ?ƐŶĂƉƐŚŽƚ ? ŵƵůƚŝƐƉĞĐƚƌĂů ŝŵĂŐŝŶŐ techniques where several 173 
wavebands are acquired simultaneously; this avoids artefacts associated with misregistration of time-174 
sequentially recorded images.[42] The simplest form of snapshot multispectral imaging involves to 175 
spliting the imaged light with an optical beam-splitter and then filter each resultant image separately 176 
with bandpass filters, or by using a dichroic mirror, [4,42] however, this becomes optically inefficient 177 
for large numbers of bands and problematic to implement with a single detector. Several snapshot 178 
multispectral imaging devices that require only a single detector have been developed, including use 179 
of a lenslet array[43] and the Image Mapping Spectrometer[44] using degmented mirrors; however to 180 
date neither of these approaches have been applied extensively to oximetry. A snapshot imaging 181 
system which has found significant use for oximetry is the Image Replicating Imaging Spectrometer 182 
(IRIS).[11,45] This optically efficient device enables video-rate imaging at eight distinct wavebands 183 
optimised for retinal oximetry. The high temporal resolution and 8 wavebands afforded by IRIS has 184 
enabled several new oximetry applications, including direct observation of oxygen release by red 185 
blood cells.[46]  186 
Table 1. Retinal oximetry studies utilising multispectral imaging oximetry 187 
algorithms. 188 
 
Study 
 
Wave-range 
 
Known 
parameters 
 
 
Estimated 
parameters 
 
 
Key reported OS  
(i.e. normal OS at normoxia - unless 
otherwise stated) 
 
Schweitzer et al., 
(1999)[47] 
510  W 586 nm 
76 wavebands 
ɸ ?ɸŵĞů K^ ?Đ ?Ě ?ɻ A: 92.2 ± 4.1 % 
V: 57.9 ± 9.9 % 
Drewes et al., 
(1999)[48] 
629, 678, 821, & 
899 nm. 
ɸ OS, S, c, d A: 101 % 
V: 65 % 
Smith et al., 
(2000)[49] 
488, 635, 670, 
752, & 830 nm 
ɸ OS, S, c, d, ɻ V: 42 - 56 % 
Alabboud et al., 
(2007)[50] 
500  W 700 nm 
27+ wavebands 
 
ɸ ? ^ K^ ?Ě ?Đ ?ɻ
 
A: 96 % 
V: 55 % 
Mordant et al., 
(2011)[51] 
500 - 650 nm 
300 wavebands 
ɸ ? ^ K^ ?Ě ?Đ ?ɻ
 
A: 104 % 
V: 35 % 
Salyer et al.,  
(2006)[52] 
420  W 700 nm 
29 wavebands 
ɸ OS, S Arterial OS correlated well with ex 
vivo blood OS measurements 
Khoobei et al., 
(2007)[53] 
522  W 586 nm 
7 wavebands 
ɸ OS A: 92 % 
V: 76 % 
Arimoto et al., 
(2010)[54] 
510  W 600 nm 
45 wavebands 
ɸ OS N/A: relative OS 
Furukawa et al., 
(2012)[54] 
510  W 600 nm 
7 wavebands 
ɸ OS N/A: relative OS 
Gao et al., 
(2012)[44] 
510 - 586 nm 
8 wavebands 
ɸ OS N/A: relative OS 
     
 189 
Key: A = arteries, V = veins. SO2 = oxygen saturation, ɸ = extinction coefficient of Hb and O2Hb, ɸmel = extinction 190 
coefficient of melanin, S = scattering contribution; c = concentration of haemoglobin, ɻ = single/double pass 191 
contribution factor; d = diameter of vessels; K = contrast reduction factor. 192 
  193 
 194 
3. BLOOD VESSELS TARGETED FOR OXIMETRY  195 
3.1. Retinal oximetry 196 
To date, the retinal vasculature has been the primary target for oximetry investigations in the eye. 197 
The retina is a site of extremely high metabolic demand, and problems with retinal blood flow can 198 
lead to a number of serious ocular conditions, including: retinal vascular occlusion[23 W26] and diabetic 199 
retinopathy.[13 W17]  Further, in ocular conditions characterised by cell loss e.g. glaucoma, estimation 200 
of oxygen utilisation has provided new insights.[18 W22] 201 
Choroidal oximetry 202 
A recent development in oximetry is the targeting of choroidal vessels for oximetry in subjects with 203 
very low retinal pigmentation. The lack of retinal pigmentation allows light to traverse through the 204 
retina and and dense choroidal vasculature. Kristjansdottir et al., (2013)[28] conducted an imaging 205 
study of OS of choroidal blood vessels in healthy subjects; results were reported in terms of ODR 206 
because ODR to OS calibration coefficients for choroidal vessels are not known and high levels optical 207 
scattering prevent the use of existing oximetry models. For example, some choroidal vessels have a 208 
negative optical density; i.e. they appear brighter than surrounding tissue. To date, a calibration 209 
scheme for choroidal oximetry calibration has not been derived. However, this study revealed a very 210 
low artery-vein difference of 4% in the choroid (instead of the typical ~30% artery-vein difference in 211 
retinal vessels).[11,28] Further studies of the choroidal circulation are required to understand what 212 
further physiological and clinical insights choroidal oximetry could bring. 213 
3.2. Bulbar conjunctival oximetry 214 
A recent oximetry study by MacKenzie et al., (2016)[32]  revealed that bulbar conjunctival blood 215 
vessels have oxygen dynamics that are remarkably different from any other blood vessels in the eye. 216 
The bulbar conjunctival blood vessels are situated within the thin conjunctival membrane on the outer 217 
surface of the sclera, and consequently are in direct contact with ambient air. This unique position of 218 
the bulbar conjunctival vessels leads to oxygen diffusion occurring from air into the bulbar conjunctival 219 
blood vessels. Consequently, all bulbar conjunctival blood vessels exposed to air will be highly 220 
oxygenated, with little to no artery-vein difference. Study of bulbar conjunctival oxygen dynamics 221 
could potentially yield insights into microvascular oxygen dynamics and related parameters. This may 222 
be of particular interest for the study of oxygen dynamics in diabetes, where microvascular vessel wall 223 
hardening is known to occur.[32] 224 
3.3. Episcleral oximetry 225 
Oximetry of the superficial episcleral blood vessels embedded into the sclera has recently been 226 
achieved for the first time by MacKenzie et al (2016).[32] This study observed that when episcleral 227 
vessels are exposed to a temporary hypoxic intervention, episcleral vessels dilated and episcleral OS 228 
decreased. This auto-regulatory behaviour is similar to the autoregulation observed in retinal vessels 229 
under similar hypoxic conditions.[11] Because episcleral vessels can be imaged on the surface of the 230 
sclera, it has been suggested that episcleral vessels could be used as a proxy for retinal OS in situations 231 
where retinal imaging is not feasible; e.g. in patients with cataracts. Alternatively, episcleral vessels 232 
could be used as a comparison point with retinal vessels to study ocular autoregulation. Further 233 
studies of episcleral vessels is required before their utility for clinically relevant oximetry can be 234 
ascertained.[32] 235 
3.4. Oximetry elsewhere in the body 236 
It is noteworthy that oximetry techniques originally developed for oximetry in the eye have 237 
benefited oximetry applications elsewhere in the body. For example, multispectral imaging oximetry 238 
has been employed to investigate diverse applications, including murine brain vascular oximetry,[55] 239 
diabetic foot-ulcer development,[56] bowel laproscopy,[57] skin blood flow,[58] the study of skin 240 
damage due to beta radiation exposure,[59] labial, periodontal, and sublingual microvasculature,[60] 241 
cancer tumour development in murine models,[39,40] and oximetry of the rat spinal cord dorsal vein 242 
for studying the development of multiple sclerosis disease models.[38] 243 
4. SPECTROSCOPIC IMAGING MODALITIES FOR THE EYE 244 
The majority of oximetry studies in the eye are conducted with retinal-fundus cameras adapted for 245 
two wavelength or multispectral imaging. Dual wavelength imaging can be enabled by splitting a 246 
broadband retinal image with a dichroic beam-splitter, spectrally filtering the resultant images, and 247 
then recording with one or more detectors.[4,31] Alternatively, wavebands may be recorded using 248 
separate channels of a three-colour RGB CCD detector with additional spectral filtering to ehance 249 
spectral discrimination.[9,38] The majority of multispectral and hyperspectral imaging studies have 250 
employed time-sequential filtering of broadband retinal images, utilising either multiple bandpass 251 
filters, a liquid-crystal tuneable filter (LCTF),[21,50,51,53,61,62] or an acousto-optic tuneable filter 252 
(AOTF) for spectral discrimination.[54,63,64] LCTFs and AOTFs offer the advantages electronically-253 
controlled optical waveband switching in short timescales (~ 50 ms and 25 µs respectively), with a 254 
wide-variety of accessible wavelengths.[65] The Image Replicating Imaging Spectrometer (IRIS) has 255 
enabled video-rate oximetry which has been utilised observe oxygen release by ex vivo red blood cells 256 
upon exposure to sodium dithionite.[46,66]  257 
 258 
Dual-wavelength scanning laser ophthalmoscopes (SLOs)[10,29,67,68] offer several advantages for 259 
retinal oximetry compared to fundus cameras, including improved control of stray light, reduced 260 
fundus light exposure levels, wide-field retinal scanning,[10] no requirement for pupil dilation,[68] and 261 
the option to incorporate adaptive optics to compensate for eye motion and improve imaging of small 262 
retinal blood vessels.[29] Recently this has enabled retinal oximetry of infants without mydriasis.52 263 
However, despite these advantages, SLOs are limited to available laser wavelengths, which are not 264 
optimal for oximetry,[33] so further development and testing of SLO oximetry systems is required. 265 
 266 
Slit lamps have not yet been utilised for oximetry, but could be modified for multispectral imaging. 267 
The high mangification and resolution of slit lamps could enable oximetry of blood vessels as small as 268 
individual capillaries and groups of red blood cells in the bulbar conjunctiva.[27]  269 
 270 
Figure 3. Psuedo-colour OS map of retinal vessels in an infant obtained via imaging with 271 
a scanning laser ophthalmoscope. Red indicates 100% OS, purple 0% OS. Figure 272 
reproduced from Vehmeijer et al., (2016) under a Creative Commons BY license[68] 273 
Optical Coherence Tomography (OCT) is emerging as a potential retinal oximetry technology, but 274 
to date OCT oximetry has been applied only to murine models. In OCT, light backscattered from tissue 275 
is collected, and by coherence gating, is processed to form a 3D volumetric image of tissue. The ranging 276 
function of OCT provides the enhanced possibility of good control of the light paths defining optical 277 
absorption and with a reduced influence of scattering Spectroscopic Optical Coherence Tomography 278 
(S-OCT) has recently emerged as technology capable of recording 3D maps of OS with high spatial 279 
resolution. [69 W71] Initially, S-OCT systems utilised the near infra-red illumination wavelengths 280 
commonly used by OCT systems. Unfortunately, near infra-red wavelengths suffer from weak optical 281 
absorption contrast between Hb and O2Hb, resulting in sub-optimal oximetry. Consequently, newer S-282 
OCT oximetry systems have improved oximetry capability by switching to visible wavelength 283 
illumination; visible wavelengths provide improved spectral contrast for oximetry. [72,73] However, 284 
S-OCT requires long acquisition times of up to 20 minutes for data acquisition. As such S-OCT oximetry 285 
studies have been conducted in murine models only. [74 W76] 286 
Photoacoustic imaging has recently emerged as a hybrid imaging modality that combines optical 287 
spectral contrast with the tissue depth penetration of ultrasound. In photoacoustic imaging, high 288 
intensity pulsed laser light (typically < 10 ns duration per pulse) is incident on the target tissue, heating 289 
the blood by less than 0.1°C and leading to rapid expansion and contraction which generates an 290 
ultrasound pulse with an amplitude proportional to the absorption of light by blood.[77] Ultrasound 291 
imaging of the emission  therefore enables deep-tissue volumetric mapping of optical absorption. 292 
However, the high laser powers required for photoacoustic signal generation and requirement for 293 
ultrasonic transducer coupling to the eye make photoacoustic imaging a less attractive prospect for 294 
oximetry in the human eye compared to oximetry with fundus cameras. So far all photoacoustic 295 
studies of the eye have been limited to murine models. A good overview of photoacoustic ophthalmic 296 
imaging has been provided by Liu and Zhang (2016).[78]  297 
  298 
5. VALIDATION AND TESTING OF OXIMETRY MEASUREMENTS 299 
5.1 Oxygen-sensitive challenges and interventions  300 
Oxygen-sensitive physiological challenges and interventions alter OS in subjects, allowing the 301 
oximetry capability of measurement systems to be assessed, and to provide useful calibration points 302 
for oximetry.[1,3,31,38,74] Further, these challenges and interventions provide physiological insights 303 
into metabolism.  304 
5.1.1. Hyperoxia 305 
Perhaps the most commonly used oxygen sensitive intervention is short duration hyperoxia (i.e. an 306 
excess of O2), where a subject breathes a high O2 (typically 100% O2) air mixture. Hyperoxia greatly 307 
increases the partial pressure of oxygen (pO2) in blood and increases both venous and arterial OS.  308 
Using the Oxymap system, Hardarson et al., (2006)[4]  reported that retinal arterial OS is increased 309 
from 96 ± 9% OS (mean  ±  SD) at normoxia to 101 ± 8 % OS at hyperoxia. Retinal veins experience a 310 
greater increase in OS from 55 ± 14 % to 78 ± 15%.[4] Using the Imedos system, Hammer et al., 311 
(2008)[9] reported that retinal arterial OS increased from 98 ± 10% (mean  ±  SD) at normoxia to 100 312 
± 10 % at hyperoxia and that retinal venous OS increased from 65 ± 12% at normoxia to 72 ± 10 % at 313 
hyperoxia.[9] Also using the Oxymap system, Klefter et al., (2014)[79] reported that retinal arterial OS 314 
increased from 95.1 ± 5.0% (mean  ±  SD) at normoxia to 96.6 ±  6.4% at hyperoxia and that retinal 315 
venous OS increased from 62.9 ± 6.7% at normoxia to 70.3 ± 7.8% at hyperoxia. Notably retinal and 316 
veins constricted in diameter by 5.5% and 8.2%, respectively at hyperoxia compared with normoxia. 317 
In all cases the increase in retinal venous OS was greater than the increase in retinal arterial OS. 318 
A hyperoxia intervention was used by Krisjandottir et al., (2013)[28] to show that all choroidal 319 
vessels are highly oxygenated at normoxia; this could only have been achieved with a hyperoxia 320 
intervention because two-wavelength oximetry calibration has not yet been demonstrated for 321 
choroidal vessels.[28] 322 
5.1.2. Hypoxia 323 
An alternative OS-sensitive intervention is acute mild hypoxia, where systematic OS is decreased 324 
by subjects inhaling a hypoxic air mixture (typically ~ 15% O2) for several minutes.  The 10 - 15 % OS 325 
decrease induced by acute mild hypoxia studies is similar in magnitude to the decrease in OS 326 
experience in high-altitude airplane travel [80] and thus can be considered safe in healthy subjects for 327 
short durations.  328 
Choudhary et al., (2013)[11] investigated the auto-regulatory effects of acute mild hypoxia in 329 
retinal vessels. OS was observed to decrease for both arterioles and venules but artery-vein (AV) OS 330 
difference remained constant. Both retinal arteries and veins were observed to dilate under hypoxia, 331 
with arteries showing a larger increase.[11] This provided new insight into the interplay between the 332 
vascular and choroidal oxygen supplies in the retina and auto-regulatory responses.  333 
MacKenzie et al., (2016)[32] utilised a similar hypoxia intervention to study bulbar conjunctival and 334 
episcleral oxygen dynamics. Episcleral vessels were observed to behave similarly to retinal vessels 335 
under acute mild hypoxia, but episcleral arteries and veins were not distinguished. However, hypoxic 336 
bulbar conjunctival vessels were observed to re-oxygenate to high OS via oxygen diffusion when 337 
exposed to ambient air. This effect would not have been possible to observe without the hypoxic 338 
intervention.[32] 339 
Severe graded hypoxia to as low as 9% O2 was used by Yi et al., (2015)[74] to investigate the 340 
metabolic response of the rat retina to hypoxia, finding that the metabolic demand of the retina is 341 
increased at hypoxia.[74] 342 
5.1.3. Retinal light exposure 343 
Retinal light exposure is known to alter retinal metabolic demand, thus inducing an autoregulation 344 
effect, and thus altering retinal OS. Using the Oxymap system, Hardarson et al., (2009)[8] found that 345 
retinal OS of both arteries and veins is higher in for an eye not exposed to light than for an eye exposed 346 
to light.[8] With the Imedos system, Hammer et al., (2011)[6] found that retinal venous OS increased 347 
by an average of ~ 5% after ~ 100s of  12.5 Hz flicker stimulation. In contrast, retinal arterial OS 348 
decreased slightly on average by ~ 1%. The diameter of both arteries and veins increased significantly, 349 
indicating increased blood flow. A later study by Hammer et al., (2012)[7] that compared diabetic 350 
patients to healthy controls found that venous OS of diabetic patients increased less under flicker 351 
stimulation than the change observed in healthy controls.[7] Similarly, venous dilation was less for 352 
diabetic patients than healthy controls. This suggests that retinal blood flow regulation is impaired in 353 
diabetic patients.[7] 354 
5.2. Eye-mimicking ex vivo oximetry phantoms 355 
Oximetry can be validated using ex vivo blood of various OS levels in in vitro phantoms that mimic 356 
blood vessels within the eye. Various strategies to phantom design and construction have been 357 
implemented. 358 
Lemaillet et al., (2009)[81] developed a multi-layered dynamic eye phantom, incorporating flowing 359 
blood to simulate in vivo blood flow. Flowing blood is known to have different reflectance and 360 
scattering parameters than static blood due to alignment of red blood cells in laminar flow 361 
conditions.[82,83] The phantom consisted of: a plano-convex lens to mimic the human lens, a choroid 362 
mimicking layer, and a layer mimicking the retinal pigment endothelium. A 100 µm capillary was 363 
supplied with flowing bovine blood from a reservoir, and OS was modified by adding sodium 364 
hydrosulphide to deoxygenate blood, with additional oxygen supplied via a fuel cell to the blood 365 
reservoir. It was noted that construction of this phantom was highly time consuming.[81] 366 
Mordant et al., (2011)[62] constructed a simple model eye consisting of straight quartz capillaries 367 
of various inner diameters (50, 100, and 150 µm) filled with static human blood (see Figure 4). A convex 368 
lens mimicked the human lens and distilled water mimicked the vitreous humour. A white diffuse 369 
reflectance material - Spectralon ? - mimicked the scleral back-reflectance.[30,84] Blood OS was varied 370 
by placing samples in air mixtures with varied fractions of O2 and OS was confirmed with a blood gas 371 
analyser.[62] This phantom was used to validate later in vivo oximetry studies.[51] 372 
MacKenzie et al., (2016)[32] constructed a simple sclera-mimicking phantom for bulbar 373 
conjunctival and episcleral oximetry. This phantom consisted of a 100 µm FEP plastic capillary above 374 
a Spectralon ?ďĂĐŬŝŶŐ ?dŚĞĐĂƉŝůůĂƌǇǁĂƐĨŝůůĞĚǁŝƚŚ flowing ex vivo equine blood and OS was varied by 375 
addition of sodium dithionite[66]; OS was confirmed with a blood gas analyser. Whilst not 376 
sophisticated, this phantom was sufficient for oximetry validation.[32] 377 
Recently, Ghassemi et al., (2015)[85,86] have reported a bio-mimicking phantom designed from 378 
real retinal blood vessel patterns. These phantoms are 3D printed from a photoreactive resin in a 379 
pattern based up a 3D sectioned image of retinal vessels. A commercially available O2Hb solution was 380 
used in place of whole blood. Yeast was used to consume oxygen in the solution, with OS decreasing 381 
over time.[85] Bio-mimicking phantoms may be advantageous in future because they could simulate 382 
realistic blood flow patterns and thus reproduce features like laminar flow seen in branching retinal 383 
veins.[42] 384 
Corcoran et al., (2014)[87] created an advanced, wide-field spherical eye with 3D-printed phantom 385 
retina, an optics based on a rigorous schematic eye model. The retina incorporated embedded image 386 
resolution test targets and simulated retinal tissue layers. This style of advanced phantom has not yet 387 
been applied to oximetry, but could be highly beneficial in future studies that more closely resemble 388 
in vivo applications.[87] 389 
 390 
Figure 4. Diagram of a model eye phantom used by Mordant et al., (2011)[62] to validate 391 
oximetry capability of a hyperspectral imaging system. Figure reproduced with 392 
permission. 393 
6. CLINICAL INSIGHTS  394 
 395 
6.1. Diabetic retinopathy 396 
 397 
Diabetic retinopathy is an important potentially blinding eye condition, which can affect patients 398 
in the working-age population. Diabetic retinopathy causes loss of capillaries in the retinal circulation, 399 
and visual loss can occur following the resultant retinal ischaemia, production of vaso-proliferative 400 
substances e.g. vascular endothelial growth factor (VEGF), and then misdirected growth of new 401 
vessels, which are fragile, and ultimately result in vitreous haemorrhage and/or retinal detachment. 402 
Diabetic visual loss can also follow leakage from retinal vessels close to the macula causing macular 403 
oedema. Research has explored the use of retinal oximetry to detect the effects on arterial and venous 404 
oxygen saturation of diabetic retinopathy. Early work by Beach et al. detailed acute changes in retinal 405 
oxygen utilisation with hyperglycaemia.[13] Later work, using dual-wavelength oximetry has 406 
demonstrated that higher venous oxygen saturation is associated with established diabetic 407 
retinopathy,[17] which, in some studies shows a dose-related relationship with increasing severity of 408 
proliferative diabetic retinopathy.[15,16] These observations might represent the formation of 409 
arterio-venous shunts in the retinal circulation to circumvent the capillary loss, or, alternatively, might 410 
simply represent reduced oxygen utilisation by pathologically atrophic inner retinal cellular elements. 411 
Elevated venous saturation in patients with diabetic retinopathy may be a clinically useful measure of 412 
underlying retinal ischaemia, and may become an indicator of the need for retinal photocoagulation 413 
treatment. Interestingly, application of retinal photocoagulation has not been shown to result in any 414 
significant changes in venous retinal OS.[15] 415 
 416 
6.2. Retinal vessel occlusion 417 
 418 
Retinal venous occlusion is an important cause of visual morbidity in older patients with general 419 
vascular risk factors, e.g. hypertension. The pathological effects of a central retinal vein occlusion may 420 
include retinal ischaemia, production of VEGF, and growth of new vessels, which can cause visual loss 421 
from vitreous haemorrhage, or neo-vascular glaucoma. Retinal oximetry research has been directed 422 
at detecting OS abnormalities. Such abnormalities might provide early evidence of retinal ischemia, 423 
and thus enable treatment to be applied at an earlier stage; hopefully reducing the risk of the patient 424 
developing neo-vascular glaucoma. Dual-wavelength oximetry research studies in central retinal 425 
venous occlusion have consistently shown lower levels of venous OS, consistent with generalised 426 
retinal ischaemia.[24, 25] Studies in partial, or branch, retinal occlusion have shown variable results, 427 
with sometimes increased, and sometimes reduced venous saturations. This may reflect the different, 428 
localised impact of a venous occlusion, and/or the maturity of the occlusion, as well as the impact of 429 
local homeostatic mechanisms.[23,26] Central retinal artery occlusion has been noted to result in 430 
severe retinal hypoxia, with low arteriovenous difference, suggesting cell death. 431 
 432 
6.3. Glaucoma 433 
 434 
Glaucoma is a common cause of blindness in older patients, and a family history of glaucoma is an 435 
important risk factor. The diagnosis of glaucoma rests on detection of characteristic changes at the 436 
optic nerve head which are associated with visual field loss. Many, but not all, patients with glaucoma 437 
will have elevated intraocular pressure. The pathological change, which ultimately results in visual loss 438 
is retinal ganglion cell axon loss, which essentially results in atrophy of the cellular elements of the 439 
inner retina. Oximetry studies have investigated the changes in oxygen consumption within the retinal 440 
circulation that are associated with the cellular loss. Research work using both dual wavelength and 441 
multispectral imaging has demonstrated elevated venous saturation, with some studies showing 442 
increasingly elevated venous saturation in more severely affected eyes.[18 W22] These studies suggest 443 
a role for retinal oximetry as a means to estimate inner retinal oxygen consumption in glaucoma and 444 
other optic neuropathies. Further research is required to investigate whether interventions to lower 445 
the intraocular pressure might demonstrate reversible changes in oxygen utilisation, which could be 446 
a favourable prognostic outcome from the intervention. 447 
 448 
7. EXPERT COMMENTARY 449 
Oximetry in the eye has revealed a great deal about physiological norms and autoregulation in the 450 
retina. However, there is still considerable insight to be gleaned in application of oximetry to choroidal, 451 
episcleral, and bulbar conjunctival blood vessels. OS norms of these vessel beds require further study, 452 
and may provide insights into disease development and treatment.  453 
 454 
The advent of commercially available retinal oximetry systems, i.e. the Oxymap and Imedos 455 
systems have enabled retinal oximetry in the clinic, which has allowed studies of many retinal diseases 456 
with increasing statistical power. Clinical studies hold the potential to provide deeper insight into 457 
disease development and treatment of conditions such as diabetic retinopathy,[13 W17] glaucoma,[18 W458 
22] and retinal vessel occlusion.[23 W26] 459 
 460 
The use of oxygen-sensitive interventions such as hyperoxia, hypoxia, and retinal light exposure 461 
have been able to compliment oximetry measurements on provide comparative intervention tests. In 462 
the retina a flicker intervention has enabled comparisons of the metabolic response of healthy control 463 
subjects and patients with diabetic retinopathy.[6] Notably, oxygen-sensitive interventions have 464 
enabled insight into the fundamental physiology of oxygen supply to the choroidal vessels,[28] 465 
episcleral circulation, and bulbar conjunctival circulation.[27] There is much potential in investigating 466 
these new targets for oximetry. 467 
 468 
The development of new technology and innovation in image processing is also helping to drive 469 
new oximetry applications that were not previously possible. With improved techniques, oximetry is 470 
now possible in small retinal vessels,[29] in the choroid,[28]  in the episcleral and bulbar conjunctival 471 
vessels,[32] and in the retina of infants.[68] New applications will invariably find new insights into the 472 
eye which are fundamentally and clinically important. 473 
 474 
One of the fundamental challenges for oximetry is validation of measurements. Arterial OS can be 475 
compared to invasive blood gas measurements or pulse oximetry. However, venous calibration is 476 
extremely challenging, and is influenced by blood vessel diameter and fundus pigmentation.[9,31] 477 
DƵůƚŝƐƉĞĐƚƌĂů ĂůŐŽƌŝƚŚŵƐ ŽĨĨĞƌ Ă  ?ĐĂůŝďƌĂƚŝŽŶ ĨƌĞĞ ? ŽǆŝŵĞƚƌǇ ŵĞƚŚŽĚ ? ďƵƚ ĂĐĐƵƌĂƚĞ ǀĂůŝĚĂƚŝŽŶ ŝƐ Ɛƚŝůů478 
highly challenging due to the complex optical environment of the eye. Validation with ex vivo blood is 479 
also complicated by numerous factors including blood aggregation, red blood cell death, alignment of 480 
red blood cells under flow, and imperfect phantoms.[12,51,81] 481 
 482 
Five-year view 483 
In the last five years, oximetry has revealed the fundamental physiology of OS in episcleral 484 
vessels,[27] the bulbar conjunctival vessels,[27] and the choroidal circulation.[28] The physiology 485 
understanding of these vessel beds has been enabled by the development of hyperoxia and hypoxia 486 
OS-sensitive interventions.  487 
Application of oximetry to the eye is continuing to yield fresh insight into the physiology of the eye 488 
and ocular disease development, and treatment. Commercially available two-wavelength oximetry 489 
systems have enabled oximetry in the clinic and studies of diseases such as diabetic retinopathy, vessel 490 
occlusion, and glaucoma have resulted. In the next five years, oximetry will likely be applied to 491 
increasingly diverse disease applications. 492 
Imaging technology and imaging analysis is also continuing to develop, pushing new boundaries in 493 
spatial and temporal resolution. This can enable oximetry in new applications, such as the study of 494 
small retinal vessels,[29] oximetry in infants,[68] in ex vivo red blood cells.[46] The advent of 3D 495 
printing has allowed the development of bio-mimicking phantoms[87] based on real blood vessel 496 
network patterns,[85] enabling the study of blood flow in realistic yet controlled scenarios. The fast 497 
paced development of 3D printing makes this field of phantom development particularly promising.  498 
Key issues  499 
 Spectroscopic oximetry is most widely applied to the study of the retinal circulation, but 500 
oximetry of the bulbar conjunctival, episcleral, and choroidal circulations has also recently 501 
emerged. 502 
 Oxygen-sensitive interventions such as hyperoxia, hypoxia, and retinal flicker illumination 503 
provide oximetry validation, clinical insights, and have revealed fundamental physiology of 504 
the choroid, the episcleral vessels, and the bulbar conjunctival vessels. 505 
 Commercial oximetry systems have enabled clinical studies in individual patients and in larger 506 
group studies, enabling deeper understanding of the development and treatment of diseases 507 
such as diabetes, retinal vessel occlusion, and glaucoma.  508 
 Development of new imaging capabilities, advanced image processing concepts, and ever-509 
improving phantom development are continuing to push new oximetry applications and 510 
enable fresh insights into the physiology of the eye. 511 
 512 
7. CONCLUSIONS 513 
Oximetry has enabled many insights in the fundamental physiology and oxygen dynamics of the 514 
eye. In particular, oximetry has enabled the study of retinal autoregulation, retinal disease 515 
development, and retinal disease treatment. Recently, the fundamental oxygen dynamics of the 516 
bulbar conjunctiva, the episcleral vessels, and the choroid have been revealed by oximetry combined 517 
with complimentary OS-sensitive hyperoxia and hypoxia interventions. 518 
Commercially available retinal oximetry systems have enabled oximetry in the clinic, allowing 519 
studies of retinal OS in many diseases and treatments. In particular, diabetic retinopathy, retinal 520 
vascular occlusion, and glaucoma. Oxygen sensitive interventions - such as retinal flicker illumination, 521 
hypoxia, and hyperoxia - have provided means to validate oximetry, establish physiological norms, 522 
and probe auto-regulation responses.  523 
The predominant imaging systems in the field of retinal oximetry are based upon modified retinal-524 
fundus cameras, however SLO-based systems show considerable promise with a comparatively larger 525 
field of view, the potential for improved spatial and depth resolution and accuracy. Further, SLOs 526 
require no mydriasis. Yet, existing SLO systems are limited to commercially favoured laser 527 
wavelengths, and as such may provide sub-optimal oximetry measurements. Confocal SLOs offer 528 
potential for improved accuracy through improved control of stray light and the longer effect path 529 
lengths enable good oximetric contrast with a wide range of low-cost infrared lasers, although optical 530 
efficiency is necessarily lower. Further development of SLO oximetry systems is a particularly fertile 531 
area. 532 
New oximetry applications are currently emerging, namely oximetry of the small retinal vessels, 533 
retinal oximetry in infants, and oximetry of the bulbar conjunctiva, episcleral, and choroidal vessels. 534 
These new applications for oximetry will enable researchers to understand the OS in physiological 535 
norms and disease across multiple ocular blood vessel beds. 536 
  537 
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